Seeing Is Believing
Currently out of the existing stock ratings of Calvin Sternick, 8 are a BUY (80%), 2 are a HOLD (20%).
Analyst Calvin Sternick, carries an average stock price target met ratio of 70% that have a potential upside of 16.2% achieved within 128 days. Previously, Calvin Sternick worked at JPMORGAN.
Calvin Sternick’s has documented 20 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CNC, Centene Corp at 10-Jul-2024.
Analyst best performing recommendations are on MOH (MOLINA HEALTHCARE).
The best stock recommendation documented was for CNC (CENTENE CORP) at 7/10/2024. The price target of $80 was fulfilled within 55 days with a profit of $13.34 (20.01%) receiving and performance score of 3.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Jul-2025
$67
$0.58 (0.87%)
$60
1 months 11 days ago
(04-Aug-2026)
4/6 (66.67%)
$2.93 (4.57%)
25
Buy Since 26-Oct-2017
$79
$12.58 (18.94%)
$36
1 months 12 days ago
(03-Aug-2026)
4/11 (36.36%)
$15.24 (23.90%)
269
Hold Since 30-May-2024
$66
$-0.42 (-0.63%)
$28
1 months 17 days ago
(29-Jul-2026)
3/5 (60%)
$4.18 (6.76%)
201
Buy Since 29-Apr-2026
$80
$13.58 (20.45%)
$75
1 months 17 days ago
(29-Jul-2026)
6/14 (42.86%)
$18.18 (29.41%)
103
Hold Since 31-Oct-2025
$65
$-1.42 (-2.14%)
$47
2 months 1 days ago
(14-Jul-2026)
3/4 (75%)
$-3.72 (-5.41%)
66